Merck KGaA (ETR:MRK)
111.45
+2.30 (2.11%)
Apr 28, 2026, 5:36 PM CET
Merck KGaA Revenue
In the year 2025, Merck KGaA had annual revenue of 21.10B EUR, down -0.26%. Merck KGaA had revenue of 5.25B in the quarter ending December 31, 2025, a decrease of -3.12%.
Revenue
21.10B
Revenue Growth
-0.26%
P/S Ratio
2.30
Revenue / Employee
357.19K
Employees
59,077
Market Cap
48.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.10B | -54.00M | -0.26% |
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.30B |
| Bayer Aktiengesellschaft | 45.58B |
| Fresenius SE & Co. KGaA | 22.87B |
| Sartorius Aktiengesellschaft | 3.55B |
| Fresenius Medical Care AG | 19.63B |
| Ottobock SE & Co. KGaA | 1.68B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
Merck KGaA News
- 5 weeks ago - TrumpRx lists many medicines at prices higher than paid in UK - Reuters
- 7 weeks ago - Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings - WSJ
- 7 weeks ago - Merck KGaA sees earnings decline of up to 4% - Reuters
- 5 months ago - Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case - WSJ
- 5 months ago - Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters
- 5 months ago - Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders - Business Wire
- 5 months ago - Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units - WSJ
- 5 months ago - Merck KGaA's Q3 profit rises, beats market view - Reuters